Spatial Profile of Tumors - Trial NCT06298773
Access comprehensive clinical trial information for NCT06298773 through Pure Global AI's free database. This phase not specified trial is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS and is currently Not yet recruiting. The study focuses on Solid Tumors. Target enrollment is 1000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Timeline & Enrollment
N/A
Mar 05, 2024
Dec 30, 2028
Primary Outcome
Spatial analysis of cancer cells
Summary
The research project focuses on analyzing the spatial organization of cells within various
 solid tumors, utilizing advanced technologies enabling in-depth multi-parametric analysis of
 tumor and immune cells. The primary objective is to understand the spatial distribution of
 cellular subpopulations within each type of tumor, while secondary objectives include
 correlating these data with clinical aspects and identifying potential therapeutic targets.
 The study involves 1000 patients with primary or metastatic tumors and spans a duration of 5
 years, from 2024 to 2028. No experimental treatments are planned; rather, only spatial
 imaging analyses with multiple markers will be conducted. Data analysis involves descriptive
 statistical methods and hypothesis testing to generate hypotheses for subsequent studies. The
 analyses will be performed using SPSS® version 21.0 software for Windows®.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06298773
Non-Device Trial